ATE377421T1 - Isochinolinderivate, verfahren zu ihrer herstellung und ihre verwendung um melatonin system-probleme zu behandeln - Google Patents

Isochinolinderivate, verfahren zu ihrer herstellung und ihre verwendung um melatonin system-probleme zu behandeln

Info

Publication number: ATE377421T1
Authority: AT; Austria
Prior art keywords: treat; production; isoquinoline derivatives; system problems; melatonin system
Prior art date: 2003-04-09

Application number

AT04290918T

Other languages

English (en)

Inventor

Sophie Poissonnier-Durieux

Valerie Wallez

Anne Gasnereau

Said Yous

Daniel Lesieur

Philippe Delagrange

Pierre Renard

Caroline Bennejean

Jean Albert Boutin

Valerie Audinot

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-09

Filing date

2004-04-07

Publication date

2007-11-15

2004-04-07 Application filed by Servier Lab filed Critical Servier Lab

2007-11-15 Application granted granted Critical

2007-11-15 Publication of ATE377421T1 publication Critical patent/ATE377421T1/de

Links

YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title 1
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical class C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 title 1
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title 1
229960003987 melatonin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45F—TRAVELLING OR CAMP EQUIPMENT: SACKS OR PACKS CARRIED ON THE BODY
- A45F5/00—Holders or carriers for hand articles; Holders or carriers for use while travelling or camping
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45F—TRAVELLING OR CAMP EQUIPMENT: SACKS OR PACKS CARRIED ON THE BODY
- A45F5/00—Holders or carriers for hand articles; Holders or carriers for use while travelling or camping
- A45F5/1516—Holders or carriers for portable handheld communication devices, e.g. pagers or smart phones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B45/00—Hooks; Eyes
- F16B45/02—Hooks with pivoting or elastically bending closing member
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45F—TRAVELLING OR CAMP EQUIPMENT: SACKS OR PACKS CARRIED ON THE BODY
- A45F5/00—Holders or carriers for hand articles; Holders or carriers for use while travelling or camping
- A45F2005/006—Holders or carriers for hand articles; Holders or carriers for use while travelling or camping comprising a suspension strap or lanyard

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
General Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Nutrition Science (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Mechanical Engineering (AREA)
Child & Adolescent Psychology (AREA)
Gynecology & Obstetrics (AREA)

AT04290918T 2003-04-09 2004-04-07 Isochinolinderivate, verfahren zu ihrer herstellung und ihre verwendung um melatonin system-probleme zu behandeln ATE377421T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0304381A FR2853649B1 (fr)	2003-04-09	2003-04-09	Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
ATE377421T1 true ATE377421T1 (de)	2007-11-15

Family

ID=32865399

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04290918T ATE377421T1 (de)	2003-04-09	2004-04-07	Isochinolinderivate, verfahren zu ihrer herstellung und ihre verwendung um melatonin system-probleme zu behandeln

Country Status (30)

Country	Link
US (2)	US7214689B2 (de)
EP (1)	EP1466604B1 (de)
JP (1)	JP4195869B2 (de)
KR (1)	KR100673702B1 (de)
CN (1)	CN100497313C (de)
AR (1)	AR043997A1 (de)
AT (1)	ATE377421T1 (de)
AU (1)	AU2004201595B2 (de)
BR (1)	BRPI0401031A (de)
CA (1)	CA2462939C (de)
CY (1)	CY1107158T1 (de)
DE (1)	DE602004009849T2 (de)
DK (1)	DK1466604T3 (de)
EA (1)	EA007714B1 (de)
EG (1)	EG24369A (de)
ES (1)	ES2295794T3 (de)
FR (1)	FR2853649B1 (de)
GE (1)	GEP20053636B (de)
HR (1)	HRP20070549T3 (de)
MA (1)	MA27070A1 (de)
MX (1)	MXPA04003200A (de)
MY (1)	MY136928A (de)
NO (1)	NO327107B1 (de)
NZ (1)	NZ532221A (de)
PL (1)	PL1466604T3 (de)
PT (1)	PT1466604E (de)
SG (1)	SG145542A1 (de)
SI (1)	SI1466604T1 (de)
UA (1)	UA81610C2 (de)
ZA (1)	ZA200402657B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2881138B1 (fr) *	2005-01-27	2007-03-02	Servier Lab	Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1731507A1 (de)	2005-04-26	2006-12-13	Institut National des Sciences Appliquees de Rouen (INSA)	Neue heterocyclische Verbindungen, ihre Herstellung und ihre Anwendung als Arzneimittel besonders als Anti-alzheimer mittel
CN100386319C (zh) *	2005-12-05	2008-05-07	中国人民解放军第二军医大学	具有抗生育和抗真菌活性的四氢异喹啉类化合物或其盐类
US8389544B2 (en) *	2007-01-17	2013-03-05	The Hong Kong University Of Science And Technology	Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2
WO2009118765A2 (en) *	2008-03-28	2009-10-01	Panacea Biotec Limited	Novel monoamine re-uptake inhibitor
ES2580702B1 (es)	2015-02-25	2017-06-08	Palobiofarma, S.L.	Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
WO2022022542A1 (zh) *	2020-07-28	2022-02-03	上海翰森生物医药科技有限公司	双环类衍生物调节剂、其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU189764B (en) *	1983-10-25	1986-07-28	Richter Gedeon Vegyeszeti Gyar Rt,Hu	Process for preparing 1-(bis (substituted methyl)-methyl)-isoquinoline-derivatives
US4584379A (en) *	1985-01-22	1986-04-22	Merrell Dow Pharmaceuticals Inc.	Isoquinoline thromboxane synthetase inhibitors
DE3640641A1 (de) *	1986-11-28	1988-07-14	Thomae Gmbh Dr K	Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3718570A1 (de) *	1987-06-03	1988-12-15	Boehringer Ingelheim Kg	Benzo- und thieno-3,4-dihydro-1- pyridinylessigsaeurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2658818B1 (fr) *	1990-02-27	1993-12-31	Adir Cie	Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE197706T1 (de) *	1993-12-21	2000-12-15	Boehringer Ingelheim Pharma	Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
FR2729147A1 (fr) *	1995-01-11	1996-07-12	Adir	Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0837850B1 (de) *	1995-06-27	2004-09-01	Takeda Chemical Industries, Ltd.	4-acylamino(halogen)alkyl-chinolin derivate, deren herstellung und deren verwendung als melatonin-agonisten
FR2778662B1 (fr) *	1998-05-12	2000-06-16	Adir	Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2801885B1 (fr) *	1999-12-06	2002-01-11	Adir	Nouveaux derives (dihydro)benzoxaziniques et (dihydro) benzothiaziniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2172376B1 (es) *	2000-01-28	2003-11-16	Servier Lab	Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

2003
- 2003-04-09 FR FR0304381A patent/FR2853649B1/fr not_active Expired - Fee Related
2004
- 2004-01-01 ZA ZA200402657A patent/ZA200402657B/xx unknown
- 2004-03-26 MA MA27596A patent/MA27070A1/fr unknown
- 2004-03-30 NO NO20041313A patent/NO327107B1/no not_active IP Right Cessation
- 2004-03-31 JP JP2004104291A patent/JP4195869B2/ja not_active Expired - Lifetime
- 2004-04-02 SG SG200401893-3A patent/SG145542A1/en unknown
- 2004-04-05 MX MXPA04003200A patent/MXPA04003200A/es active IP Right Grant
- 2004-04-06 CA CA2462939A patent/CA2462939C/fr not_active Expired - Fee Related
- 2004-04-07 PL PL04290918T patent/PL1466604T3/pl unknown
- 2004-04-07 DK DK04290918T patent/DK1466604T3/da active
- 2004-04-07 PT PT04290918T patent/PT1466604E/pt unknown
- 2004-04-07 SI SI200430535T patent/SI1466604T1/sl unknown
- 2004-04-07 BR BR0401031-0A patent/BRPI0401031A/pt not_active IP Right Cessation
- 2004-04-07 UA UA2004042636A patent/UA81610C2/ru unknown
- 2004-04-07 EG EG2004040161A patent/EG24369A/xx active
- 2004-04-07 AR ARP040101179A patent/AR043997A1/es active IP Right Grant
- 2004-04-07 GE GE5500A patent/GEP20053636B/en unknown
- 2004-04-07 ES ES04290918T patent/ES2295794T3/es not_active Expired - Lifetime
- 2004-04-07 EP EP04290918A patent/EP1466604B1/de not_active Expired - Lifetime
- 2004-04-07 DE DE602004009849T patent/DE602004009849T2/de not_active Expired - Lifetime
- 2004-04-07 CN CNB2004100310343A patent/CN100497313C/zh not_active Expired - Fee Related
- 2004-04-07 AT AT04290918T patent/ATE377421T1/de active
- 2004-04-08 NZ NZ532221A patent/NZ532221A/en not_active IP Right Cessation
- 2004-04-08 EA EA200400409A patent/EA007714B1/ru not_active IP Right Cessation
- 2004-04-08 US US10/820,904 patent/US7214689B2/en not_active Expired - Fee Related
- 2004-04-08 MY MYPI20041285A patent/MY136928A/en unknown
- 2004-04-08 AU AU2004201595A patent/AU2004201595B2/en not_active Ceased
- 2004-04-09 KR KR1020040024442A patent/KR100673702B1/ko not_active Expired - Fee Related
2007
- 2007-03-20 US US11/725,855 patent/US20070191328A1/en not_active Abandoned
- 2007-12-04 HR HR20070549T patent/HRP20070549T3/xx unknown
2008
- 2008-01-28 CY CY20081100097T patent/CY1107158T1/el unknown

Also Published As

Publication number	Publication date
KR100673702B1 (ko)	2007-01-24
CA2462939A1 (fr)	2004-10-09
EG24369A (en)	2009-03-15
NZ532221A (en)	2005-07-29
CA2462939C (fr)	2010-04-27
EA200400409A1 (ru)	2004-10-28
MXPA04003200A (es)	2004-10-14
DE602004009849T2 (de)	2008-09-04
NO327107B1 (no)	2009-04-20
EP1466604A1 (de)	2004-10-13
MA27070A1 (fr)	2004-12-20
SG145542A1 (en)	2008-09-29
SI1466604T1 (sl)	2008-02-29
MY136928A (en)	2008-11-28
CN100497313C (zh)	2009-06-10
ES2295794T3 (es)	2008-04-16
UA81610C2 (ru)	2008-01-25
FR2853649A1 (fr)	2004-10-15
CY1107158T1 (el)	2012-10-24
US20040204449A1 (en)	2004-10-14
ZA200402657B (en)	2004-10-14
JP4195869B2 (ja)	2008-12-17
AR043997A1 (es)	2005-08-17
NO20041313L (no)	2004-10-11
US7214689B2 (en)	2007-05-08
AU2004201595B2 (en)	2010-01-21
AU2004201595A1 (en)	2004-10-28
KR20040087964A (ko)	2004-10-15
FR2853649B1 (fr)	2006-07-14
EA007714B1 (ru)	2006-12-29
PT1466604E (pt)	2007-12-21
BRPI0401031A (pt)	2005-01-18
JP2004307492A (ja)	2004-11-04
HRP20070549T3 (en)	2008-07-31
HK1067121A1 (zh)	2005-04-01
GEP20053636B (en)	2005-10-10
DE602004009849D1 (de)	2007-12-20
PL1466604T3 (pl)	2008-03-31
EP1466604B1 (de)	2007-11-07
US20070191328A1 (en)	2007-08-16
CN1535957A (zh)	2004-10-13
DK1466604T3 (da)	2008-03-03

Legal Events

Date

Code

Title

Description

2008-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1466604

Country of ref document: EP

Publication	Publication Date	Title
DE60313602D1 (de)	2007-06-14	N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG
ATE348609T1 (de)	2007-01-15	Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
ATE347890T1 (de)	2007-01-15	Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren
DE10393704D2 (de)	2005-07-21	Nancomposite, Verfahren zu ihrer Herstellung und ihre Verwendung
DE502004011957D1 (de)	2011-01-13	Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE502005009723D1 (de)	2010-07-22	Arylsubstituierte heterozyklen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE476412T1 (de)	2010-08-15	Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
DE502005007840D1 (de)	2009-09-17	7-phenylamino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE60313818D1 (de)	2007-06-28	Dialysator und Verfahren zu dessen Herstellung
ATE327981T1 (de)	2006-06-15	Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
DE50310782D1 (de)	2008-12-24	Piezoaktor und verfahren zu dessen herstellung
ATE482193T1 (de)	2010-10-15	Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
ATE473738T1 (de)	2010-07-15	1-sulfonylindolderivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht6 liganden
DE602004008991D1 (de)	2007-10-31	Umlenkbeschlag und verfahren zu dessen herstellung
ATE535510T1 (de)	2011-12-15	Benzylamine, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmende mittel
DE50307832D1 (de)	2007-09-13	Schichtsystem und verfahren zu dessen herstellung
ATE517092T1 (de)	2011-08-15	Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE50011179D1 (de)	2005-10-20	Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE377421T1 (de)	2007-11-15	Isochinolinderivate, verfahren zu ihrer herstellung und ihre verwendung um melatonin system-probleme zu behandeln
ATE302765T1 (de)	2005-09-15	2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ATE404532T1 (de)	2008-08-15	Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
ATE384069T1 (de)	2008-02-15	Alkyliden-tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
ATE313556T1 (de)	2006-01-15	Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung
DE602004026157D1 (de)	2010-05-06	Proteinkomplex, verfahren zu dessen herstellung und verwendung davon
ATE356120T1 (de)	2007-03-15	2-phenyl-benzofuran-derivate, verfahren zur ihrer herstellung und ihre verwendung